Australia’s medical regulator has granted provisional approval for a Pfizer COVID-19 booster for children aged between six months and five years. The pharmaceutical company says while children are less likely to develop serious illness from COVID-19, they are still at risk of complications including long COVID-19. Pfizer’s Australia and New Zealand medical director said children […]

This post was originally published on Michael West.